Christina Madsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christina Madsen has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Sidse Marie Arnfred
Psychiatric Research Unit, Copenhagen University Hospital – Psychiatry Region Zealand, Slagelse, Denmark
3 shared publications - Oliver Rumle Hovmand
Department of Research, Central- and West Zealand Hospital, Slagelse, Denmark
2 shared publications - Anita Eskildsen
Department of Affective Disorders, Aarhus University Hospital, Aarhus, Denmark
1 shared publication - Anne Bryde Christensen
Center for Eating and Feeding Disorders Research, Mental Health Center Ballerup, Copenhagen University Hospital – Mental Health Services CPH, Copenhagen, Denmark
1 shared publication - Buddheera Bandara Wm Kumburegama
Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region, Copenhagen University Hospital — Rigshospitalet; Copenhagen Denmark
1 shared publication - Charles Chin Han Lew
Department of Dietetics and Nutrition, Ng Teng Fong General Hospital, Singapore City, Singapore; Faculty of Health and Social Sciences, Singapore Institute of Technology, Singapore City, Singapore
1 shared publication
Latest Publications
- Open Access
- 14 March 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26 (1)
The danish version of patient reported outcomes measurement information system depression and anxiety short-forms (PROMIS-D-SF 6a and PROMIS-A-SF 6a) are promising tools to screen for anxiety and depression
Patient Reported Outcomes Measurement Information System Depression Short-Form 6a (PROMIS-D-SF) and Patient Reported Outcomes Measurement Information Syste
- 14 March 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26 (1)
Open AccessThe danish version of patient reported outcomes measurement information system depression and anxiety short-forms (PROMIS-D-SF 6a and PROMIS-A-SF 6a) are promising tools to screen for anxiety and depression
Patient Reported Outcomes Measurement Information System Depression Short-Form 6a (PROMIS-D-SF) and Patient Reported Outcomes Measurement Information Syste
- Open Access
- 21 January 2025
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 9 (1) , 1-8
High fatigue levels among psychiatric outpatients – the validity of the Danish Patient Reported Outcomes Measurement Information System Fatigue Short-Form (PROMISF-SF)
Background: Patient Reported Outcomes Measurement Information System Fatigue Short-Form (PROMIS-F-SF) is a self-administered, patient reported outcome (PRO) designed to assess fatigue in healthy and clinical populations and for tracking progress during treatment for disorders complicated with fatigue. Methods: Patients in the Mental Health Service Outpatient Clinics and healthy volunteers were invited to complete a survey, which included the Danish translation of the PROMIS-F-SF, the Chalder Fatigue Scale (CFS-11), and measures of depression and anxiety. We conducted a confirmatory factor analysis of the previously suggested single-factor structure of the instrument. We furthermore evaluated the construct validity of the PROMIS-F-SF by means of its relationship with the CFS-11. Finally, we evaluated the utility of the PROMIS-F-SF to identify patient-status by conducting receiver operating characteristic curves. Results: 70 healthy volunteers and 62 patients completed the instruments. The PROMIS-F-SF had a average fit to the previously reported single-factor structure. Cronbach’s alpha and McDonald’s omega showed good internal reliability (α = 0.96, ωtotal = 0.97). PROMIS-F-SF score was positively correlated with the CFS-11 (r =.76) and it correlated highly with depression (r =.78) and anxiety (r =.74) score. The optimal cut-off point in the ROC-analyses was 15, which yielded a sensitivity of 89% and a specificity of 67% in the prediction of patient status. Conclusions: Level of fatigue among psychiatric outpatients is high in patients with psychiatric illness, compared to levels measured in healthy volunteers. The Danish PROMIS-F-SF shows good psychometric properties in this combined sample of healthy adults and psychiatric patients with non-psychotic disorders and it is recommended as PRO measure for psychiatric populations. Examination of psychometric properties in patient populations with somatic disorder could be a natural next step.
- 21 January 2025
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 9 (1) , 1-8
Open AccessHigh fatigue levels among psychiatric outpatients – the validity of the Danish Patient Reported Outcomes Measurement Information System Fatigue Short-Form (PROMISF-SF)
Background: Patient Reported Outcomes Measurement Information System Fatigue Short-Form (PROMIS-F-SF) is a self-administered, patient reported outcome (PRO) designed to assess fatigue in healthy and clinical populations and for tracking progress during treatment for disorders complicated with fatigue. Methods: Patients in the Mental Health Service Outpatient Clinics and healthy volunteers were invited to complete a survey, which included the Danish translation of the PROMIS-F-SF, the Chalder Fatigue Scale (CFS-11), and measures of depression and anxiety. We conducted a confirmatory factor analysis of the previously suggested single-factor structure of the instrument. We furthermore evaluated the construct validity of the PROMIS-F-SF by means of its relationship with the CFS-11. Finally, we evaluated the utility of the PROMIS-F-SF to identify patient-status by conducting receiver operating characteristic curves. Results: 70 healthy volunteers and 62 patients completed the instruments. The PROMIS-F-SF had a average fit to the previously reported single-factor structure. Cronbach’s alpha and McDonald’s omega showed good internal reliability (α = 0.96, ωtotal = 0.97). PROMIS-F-SF score was positively correlated with the CFS-11 (r =.76) and it correlated highly with depression (r =.78) and anxiety (r =.74) score. The optimal cut-off point in the ROC-analyses was 15, which yielded a sensitivity of 89% and a specificity of 67% in the prediction of patient status. Conclusions: Level of fatigue among psychiatric outpatients is high in patients with psychiatric illness, compared to levels measured in healthy volunteers. The Danish PROMIS-F-SF shows good psychometric properties in this combined sample of healthy adults and psychiatric patients with non-psychotic disorders and it is recommended as PRO measure for psychiatric populations. Examination of psychometric properties in patient populations with somatic disorder could be a natural next step.
- Open Access
- 9 September 2024
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 24 (1) , 1-17
Major mistakes or errors in the use of trial sequential analysis in systematic reviews or meta-analyses – the METSA systematic review
Background: Systematic reviews and data synthesis of randomised clinical trials play a crucial role in clinical practice, research, and health policy. Trial sequential analysis can be used in systematic reviews to control type I and type II errors, but methodological errors including lack of protocols and transparency are cause for concern. We assessed the reporting of trial sequential analysis. Methods: We searched Medline and the Cochrane Database of Systematic Reviews from 1 January 2018 to 31 December 2021 for systematic reviews and meta-analysis reports that include a trial sequential analysis. Only studies with at least two randomised clinical trials analysed in a forest plot and a trial sequential analysis were included. Two independent investigators assessed the studies. We evaluated protocolisation, reporting, and interpretation of the analyses, including their effect on any GRADE evaluation of imprecision. Results: We included 270 systematic reviews and 274 meta-analysis reports and extracted data from 624 trial sequential analyses. Only 134/270 (50%) systematic reviews planned the trial sequential analysis in the protocol. For analyses on dichotomous outcomes, the proportion of events in the control group was missing in 181/439 (41%), relative risk reduction in 105/439 (24%), alpha in 30/439 (7%), beta in 128/439 (29%), and heterogeneity in 232/439 (53%). For analyses on continuous outcomes, the minimally relevant difference was missing in 125/185 (68%), variance (or standard deviation) in 144/185 (78%), alpha in 23/185 (12%), beta in 63/185 (34%), and heterogeneity in 105/185 (57%). Graphical illustration of the trial sequential analysis was present in 93% of the analyses, however, the Z-curve was wrongly displayed in 135/624 (22%) and 227/624 (36%) did not include futility boundaries. The overall transparency of all 624 analyses was very poor in 236 (38%) and poor in 173 (28%). Conclusions: The majority of trial sequential analyses are not transparent when preparing or presenting the required parameters, partly due to missing or poorly conducted protocols. This hampers interpretation, reproducibility, and validity. Study registration: PROSPERO CRD42021273811
- 9 September 2024
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 24 (1) , 1-17
Open AccessMajor mistakes or errors in the use of trial sequential analysis in systematic reviews or meta-analyses – the METSA systematic review
Background: Systematic reviews and data synthesis of randomised clinical trials play a crucial role in clinical practice, research, and health policy. Trial sequential analysis can be used in systematic reviews to control type I and type II errors, but methodological errors including lack of protocols and transparency are cause for concern. We assessed the reporting of trial sequential analysis. Methods: We searched Medline and the Cochrane Database of Systematic Reviews from 1 January 2018 to 31 December 2021 for systematic reviews and meta-analysis reports that include a trial sequential analysis. Only studies with at least two randomised clinical trials analysed in a forest plot and a trial sequential analysis were included. Two independent investigators assessed the studies. We evaluated protocolisation, reporting, and interpretation of the analyses, including their effect on any GRADE evaluation of imprecision. Results: We included 270 systematic reviews and 274 meta-analysis reports and extracted data from 624 trial sequential analyses. Only 134/270 (50%) systematic reviews planned the trial sequential analysis in the protocol. For analyses on dichotomous outcomes, the proportion of events in the control group was missing in 181/439 (41%), relative risk reduction in 105/439 (24%), alpha in 30/439 (7%), beta in 128/439 (29%), and heterogeneity in 232/439 (53%). For analyses on continuous outcomes, the minimally relevant difference was missing in 125/185 (68%), variance (or standard deviation) in 144/185 (78%), alpha in 23/185 (12%), beta in 63/185 (34%), and heterogeneity in 105/185 (57%). Graphical illustration of the trial sequential analysis was present in 93% of the analyses, however, the Z-curve was wrongly displayed in 135/624 (22%) and 227/624 (36%) did not include futility boundaries. The overall transparency of all 624 analyses was very poor in 236 (38%) and poor in 173 (28%). Conclusions: The majority of trial sequential analyses are not transparent when preparing or presenting the required parameters, partly due to missing or poorly conducted protocols. This hampers interpretation, reproducibility, and validity. Study registration: PROSPERO CRD42021273811
- Open Access
- 29 August 2024
- Published by Wiley in Clinical Psychology & Psychotherapy
- Vol. 31 (5) , e3049
Validation of the Danish Version of the Overall Depression Severity and Impairment Scale (ODSIS): A Reliable Instrument for Assessing Depression Symptoms and Functional Impairment
Introduction: In psychotherapy, having a reliable tracking tool is vital for effective treatment. We have validated the Danish version of the ‘Overall Depression Severity and Impairment Scale’ (ODSIS), which is used in the Unified Protocol for Emotional Disorders (UP) and other cognitive behavioural therapies. This five‐item self‐rating scale is expected to correspond closely to the gold‐standard Beck Depression Inventory‐II (BDI‐II), but also to self‐rating scales addressing daily functioning and well‐being.Methods: Internal consistency is assessed using Cronbach's alpha and McDonald's omega. Criterion validity is explored through Pearson's correlation coefficient with BDI‐II, the Work and Social Adjustment Scale (WSAS), the Five‐Item World Health Organization Well‐Being Index (WHO‐5) and scatter plots, and an optimal cut‐off score is determined using a receiver operating characteristic curve. The study included 340 respondents: 234 from a recent clinical trial, 56 psychiatric patients from inpatient/outpatient units and 50 healthy volunteers.Results: ODSIS demonstrates strong internal consistency (Cronbach's alpha: 0.887–0.956, McDonald's omega: 0.888–0.957). Correlations with BDI‐II, WSAS and WHO‐5 highlight its strong criterion validity (BDI‐II: 0.847, WSAS: 0.751, WHO‐5: 0.771). The optimal cut‐off score (> 7.5) for detecting depression shows great sensitivity (0.862) and specificity (0.731).Conclusion: The Danish version of ODSIS proves to be a reliable instrument for quantification of a combination of depression level and functional impairment from the symptoms. Its high correlation with established BDI‐II makes it a brief and handy tool for repeated measurement in clinical and research settings.
- 29 August 2024
- Published by Wiley in Clinical Psychology & Psychotherapy
- Vol. 31 (5) , e3049
Open AccessValidation of the Danish Version of the Overall Depression Severity and Impairment Scale (ODSIS): A Reliable Instrument for Assessing Depression Symptoms and Functional Impairment
Introduction: In psychotherapy, having a reliable tracking tool is vital for effective treatment. We have validated the Danish version of the ‘Overall Depression Severity and Impairment Scale’ (ODSIS), which is used in the Unified Protocol for Emotional Disorders (UP) and other cognitive behavioural therapies. This five‐item self‐rating scale is expected to correspond closely to the gold‐standard Beck Depression Inventory‐II (BDI‐II), but also to self‐rating scales addressing daily functioning and well‐being.Methods: Internal consistency is assessed using Cronbach's alpha and McDonald's omega. Criterion validity is explored through Pearson's correlation coefficient with BDI‐II, the Work and Social Adjustment Scale (WSAS), the Five‐Item World Health Organization Well‐Being Index (WHO‐5) and scatter plots, and an optimal cut‐off score is determined using a receiver operating characteristic curve. The study included 340 respondents: 234 from a recent clinical trial, 56 psychiatric patients from inpatient/outpatient units and 50 healthy volunteers.Results: ODSIS demonstrates strong internal consistency (Cronbach's alpha: 0.887–0.956, McDonald's omega: 0.888–0.957). Correlations with BDI‐II, WSAS and WHO‐5 highlight its strong criterion validity (BDI‐II: 0.847, WSAS: 0.751, WHO‐5: 0.771). The optimal cut‐off score (> 7.5) for detecting depression shows great sensitivity (0.862) and specificity (0.731).Conclusion: The Danish version of ODSIS proves to be a reliable instrument for quantification of a combination of depression level and functional impairment from the symptoms. Its high correlation with established BDI‐II makes it a brief and handy tool for repeated measurement in clinical and research settings.